Literature DB >> 20298987

Indications and outcomes of surgical closure of ventricular septal defect in adults.

François-Pierre Mongeon1, Harold M Burkhart, Naser M Ammash, Joseph A Dearani, Zhuo Li, Carole A Warnes, Heidi M Connolly.   

Abstract

OBJECTIVES: We sought to review our experience with surgical ventricular septal defect (VSD) closure in adults.
BACKGROUND: Outcome data of VSD closure in adults on which to base recommendations are limited. Guidelines recommend closure of adult VSD for a Q(p)/Q(s) ratio > or =2, left ventricular volume overload, or endocarditis.
METHODS: We retrospectively reviewed 46 patients (mean age 33.6 +/- 11.2 years, 24 women) who underwent surgical VSD closure (1958 to 2008).
RESULTS: VSDs were classified according to the Society of Thoracic Surgeons as type 2 (membranous, 72%) or type 1 (subarterial, 26%). Aortic regurgitation (AR) (28%), left ventricular dilation (20%), and pulmonary hypertension (20%) were the most common indications for closure. Associated lesions justified surgery in 39% of patients. There were no early deaths. Morbidity included 1 high-grade atrioventricular block requiring permanent pacemaker and a residual VSD in 7 patients. Late mortality was 5% (mean follow-up: 10.3 +/- 12.4 years). Patient survival did not differ from expected survival in a reference population (p = 0.75). Late residual VSDs were more common after suture closure (6 of 8 patients). Late moderate AR developed in 5 patients (4 with a type 1 VSD) with aortic valve or sinus of Valsalva repair. The use of intraoperative transesophageal echocardiography was associated with fewer residual VSDs and less > or = moderate tricuspid valve regurgitation and AR.
CONCLUSIONS: Associated heart defects and AR were common indications for VSD closure in adults, which was performed with low mortality and morbidity. Patch closure and use of intraoperative transesophageal echocardiography improve surgical outcomes. Important residua emphasize the need for life-long informed follow-up. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20298987     DOI: 10.1016/j.jcin.2009.12.007

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  11 in total

Review 1.  Applications of 3D printing in cardiovascular diseases.

Authors:  Andreas A Giannopoulos; Dimitris Mitsouras; Shi-Joon Yoo; Peter P Liu; Yiannis S Chatzizisis; Frank J Rybicki
Journal:  Nat Rev Cardiol       Date:  2016-10-27       Impact factor: 32.419

Review 2.  Long-Term Outcomes of Surgical Repair for Ventricular Septal Defect in Adults.

Authors:  Jae Hong Lim; Sungkyu Cho; Chang-Ha Lee; Eung Re Kim; Yong Jin Kim
Journal:  Pediatr Cardiol       Date:  2022-02-18       Impact factor: 1.838

3.  Identification of nodal tissue in the living heart using rapid scanning fiber-optics confocal microscopy and extracellular fluorophores.

Authors:  Chao Huang; Aditya K Kaza; Robert W Hitchcock; Frank B Sachse
Journal:  Circ Cardiovasc Imaging       Date:  2013-06-27       Impact factor: 7.792

4.  Transthoracic closure of ventricular septal defects guided by transesophageal echocardiography.

Authors:  Huang Jiang-Shan; Sun Kai-Peng; Xu Ning; Zhang Gui-Can; Chen Qiang
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

5.  Right coronary cusp prolapse resembling subpulmonic stenosis in an old adult patient with ventricular septal defect.

Authors:  Myeong Gun Kim; Wook-Jin Chung; Chang Hyu Choi; Jeonggeun Moon; Mi-Seung Shin; Seung Hwan Han; Eak Kyun Shin
Journal:  J Cardiovasc Ultrasound       Date:  2011-12-27

6.  Cardiovascular magnetic resonance catheterization derived pulmonary vascular resistance and medium-term outcomes in congenital heart disease.

Authors:  Kuberan Pushparajah; Aphrodite Tzifa; Aaron Bell; James K Wong; Tarique Hussain; Israel Valverde; Hannah R Bellsham-Revell; Gerald Greil; John M Simpson; Tobias Schaeffter; Reza Razavi
Journal:  J Cardiovasc Magn Reson       Date:  2015-04-14       Impact factor: 5.364

7.  Percutaneous closure of perimembranous ventricular septal defect using patent ductus arteriosus occluders.

Authors:  Hieu Lan Nguyen; Quang Tan Phan; Dung Duc Doan; Linh Huynh Dinh; Hieu Ba Tran; Saima Sharmin; Julian Johny Thottian; Hoyoun Won; Wang Soo Lee; Seung Yong Shin; Truong Quang Nguyen; Sang Wook Kim
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

8.  A Comparative Study of Perventricular and Percutaneous Device Closure Treatments for Isolated Ventricular Septal Defect: A Chinese Single-Institution Experience.

Authors:  Xue-Shan Huang; Zeng-Rong Luo; Qiang Chen; Ling-Shan Yu; Hua Cao; Liang-Wan Chen; Gui-Can Zhang
Journal:  Braz J Cardiovasc Surg       Date:  2019-06-01

9.  Comparison of Fast-Track and Conventional Anesthesia for Transthoracic Closure of Ventricular Septal Defects in Pediatric Patients.

Authors:  Ling-Shan Yu; Qiang Chen; Zeng-Chun Wang; Hua Cao; Liang-Wan Chen; Gui-Can Zhang
Journal:  Ann Thorac Cardiovasc Surg       Date:  2019-03-12       Impact factor: 1.520

10.  Comparison of transcatheter versus surgical closure of perimembranous ventricular septal defect in pediatric patients: A systematic review and meta-analysis.

Authors:  Sahar El-Kadeem; Shaymaa El Nemr; Doaa El Amrousy; Amr Zoair
Journal:  J Saudi Heart Assoc       Date:  2019-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.